Please do not leave this page until complete. This can take a few moments.
The University of Massachusetts Medical School's MassBiologics laboratory has received a milestone payment from pharmaceutical manufacturer Merck. The move comes after the launch of a Phase-III clinical trial of an antibody combination drug used to treat Clostridium difficile, a gastro-intestinal bacterium, according to a UMass Medical School statement.
The drug was developed by MassBiologics and Medarex, a biotechnology division of Bristol Myers Squibb based in Princeton, N.J., and licensed by Merck.
The amount of Merck's payment was not disclosed. Merck intends to file for FDA approval of the drug in 2014, according to a spokesman for UMass Medical School.
Are you looking for a business loan, personal loans, mortgage loans, car loans, student loans, unsecured consolidation loans,project funding etc ... Or simply refuse loan from a bank or financial institution for one or more reasons? We are the right solutions for credit! We offer loans to businesses and individuals with low and affordable interest rate of 2%. So if you are Interested in an urgent and secured loan. For more information kindly email us today Via: elegantloanfirm@hotmail.com.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
1 Comments